Does CARVEDILOL Cause Interstitial lung disease? 41 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 41 reports of Interstitial lung disease have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 0.3% of all adverse event reports for CARVEDILOL.
41
Reports of Interstitial lung disease with CARVEDILOL
0.3%
of all CARVEDILOL reports
7
Deaths
34
Hospitalizations
How Dangerous Is Interstitial lung disease From CARVEDILOL?
Of the 41 reports, 7 (17.1%) resulted in death, 34 (82.9%) required hospitalization, and 5 (12.2%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 41 reports have been filed with the FAERS database.
What Other Side Effects Does CARVEDILOL Cause?
Hypotension (1,822)
Dyspnoea (1,143)
Dizziness (1,138)
Drug ineffective (1,102)
Fatigue (1,020)
Completed suicide (1,019)
Bradycardia (861)
Toxicity to various agents (690)
Cardiac failure (636)
Asthenia (562)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CARVEDILOL Alternatives Have Lower Interstitial lung disease Risk?
CARVEDILOL vs CASIMERSEN
CARVEDILOL vs CASIRIVIMAB
CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB
CARVEDILOL vs CASPOFUNGIN
CARVEDILOL vs CATEQUENTINIB